Circulating tumor cells allow researchers to detect cancer early, provide an accurate prognosis, monitor progression, and ...
Elevated baseline CTC counts are linked to worse overall survival, progression-free survival, and treatment response in cancer patients. In prostate cancer, patients with five or more CTCs at ...
Elevated baseline CTC count in hormone-sensitive prostate cancer is linked to worse overall survival and treatment response. Liquid biopsy can measure CTC count, providing a non-invasive method to ...
Please provide your email address to receive an email when new articles are posted on . Men with five or more circulating tumor cells/7.5 mL at baseline had a more than threefold risk for death ...
Circulating tumor cells (CTCs), originating from primary neoplastic tissues, infiltrate blood vessels, migrate through the bloodstream, and establish secondary tumor foci. The detection of CTCs holds ...
In a pair of studies, investigators from the lab of Huiping Liu, MD, Ph.D., associate professor of Pharmacology and of ...
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program Consecutive patients who ...
Large B-cell lymphomas (LBCL) are curable, but patients with residual disease after therapy invariably experience progression. Ultrasensitive methods to detect circulating tumor DNA (ctDNA) as minimal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback